EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Impact of Transcatheter Edge‐to‐Edge Repair in Patients With Cardiac Sarcoidosis: Insights From the OCEAN‐Mitral Registry

Takashi Hiruma iD, Mike Saji iD, Mamoru Nanasato, Itaru Takamisawa iD, Ryosuke Higuchi, Yuki Izumi, Ryo Abe iD, Mitsuaki Isobe iD, Masanori Yamamoto iD, Shunsuke Kubo iD, Masahiko Asami iD, Yusuke Enta iD und 17 weitere

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.124.039243 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Takashi Hiruma und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology Sakakibara Heart Institute Tokyo Japan. Hauptthemen laut MEDLINE: Sarcoidosis, Cardiomyopathies, Mitral Valve Insufficiency, Cardiac Catheterization. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In patients with sarcoidosis, cardiac involvement is a crucial prognostic factor leading to severe cardiovascular events. Mitral regurgitation (MR) predisposes patients to drug‐refractory heart failure; however, MR in patients with cardiac sarcoidosis (CS) has been scarcely investigated and its therapeutic approach remains unclear. This study aimed to investigate the clinical impact of transcatheter edge‐to‐edge repair in patients with CS.

Methods

Patients with CS‐related ventricular functional MR were compared with those with other nonischemic cardiomyopathies in the OCEAN (Optimized Catheter Valvular Intervention)‐Mitral registry in Japan.

Results

Among 1240 patients with nonischemic cardiomyopathy‐related ventricular functional MR, 40 (3.2%) had CS. Of these, 18 patients (45.0%) had immunosuppressive therapy. Twenty‐seven patients (67.5%) were New York Heart Association function class III/IV. Patients with CS were more likely to be younger and female, had a higher prevalence of ventricular tachyarrhythmia and cardiac resynchronization therapy, and had a larger left ventricle with more severe MR than the others. At the procedure, 38 patients (95.0%) had devices placed at the central lesion. All patients with CS were successfully treated, leading to immediate improvement of cardiac output. At 1‐year follow‐up, 89.3% had MR ≤2+ and 40.0% had New York Heart Association function class I. Despite similar outcomes between groups, greater remnant MR and fatal arrhythmic events in those with CS may be due to inadequate reverse remodeling and ongoing left ventricle damage caused by inflammation.

Conclusions

Transcatheter edge‐to‐edge repair is an effective heart failure treatment for patients with CS‐related MR; however, the drug‐ and cardiac device‐refractory cardiomyopathy in this population warrants careful management. Registration URL: www.umin.ac.jp/english/ ; Unique Identifier: UMIN000023653.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcoidosisCardiomyopathiesMitral Valve InsufficiencyCardiac CatheterizationHumansFemaleMaleRegistriesJapanMiddle AgedAgedTreatment Outcome

Stichwörter der Autor:innen

MitraClipcardiac sarcoidosismitral regurgitationtranscatheter edge‐to‐edge repair

Autor:innen und Institutionen

  • Department of Cardiology Sakakibara Heart Institute Tokyo Japan.
  • Department of Cardiovascular Medicine The University of Tokyo Tokyo Japan.
  • Division of Cardiovascular Medicine, Department of Internal Medicine Toho University Faculty of Medicine Tokyo Japan.
  • Department of Cardiology Toyohashi Heart Center Toyohashi Japan.
  • Department of Cardiology Nagoya Heart Center Nagoya Japan.
  • Department of Cardiology Gifu Heart Center Gifu Japan.

ORCID-Profile: Takashi Hiruma, Mike Saji, Itaru Takamisawa, Ryo Abe, Mitsuaki Isobe, Masanori Yamamoto, Shunsuke Kubo, Masahiko Asami, Yusuke Enta, Shinichi Shirai, Masaki Izumo, Yusuke Watanabe, Makoto Amaki, Junichi Yamaguchi, Yohei Ohno, Daisuke Hachinohe, Hiroshi Ueno, Kazuki Mizutani, Toshiaki Otsuka, Kentaro Hayashida

Zitieren

APA

Hiruma, T., Saji, M., Nanasato, M., Takamisawa, I., Higuchi, R., Izumi, Y., Abe, R., Isobe, M., Yamamoto, M., Kubo, S., Asami, M., Enta, Y., Shirai, S., Izumo, M., Mizuno, S., Watanabe, Y., Amaki, M., Kodama, K., Yamaguchi, J., …, & OCEAN‐Mitral Investigators (2025). Impact of Transcatheter Edge‐to‐Edge Repair in Patients With Cardiac Sarcoidosis: Insights From the OCEAN‐Mitral Registry. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.039243

Vancouver

Hiruma T, Saji M, Nanasato M, Takamisawa I, Higuchi R, Izumi Y, et al. Impact of Transcatheter Edge‐to‐Edge Repair in Patients With Cardiac Sarcoidosis: Insights From the OCEAN‐Mitral Registry. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.039243

BibTeX
@article{Hiruma2025,
  author = {Hiruma, Takashi and Saji, Mike and Nanasato, Mamoru and Takamisawa, Itaru and Higuchi, Ryosuke and Izumi, Yuki and Abe, Ryo and Isobe, Mitsuaki and Yamamoto, Masanori and Kubo, Shunsuke and Asami, Masahiko and Enta, Yusuke and Shirai, Shinichi and Izumo, Masaki and Mizuno, Shingo and Watanabe, Yusuke and Amaki, Makoto and Kodama, Kazuhisa and Yamaguchi, Junichi and Naganuma, Toru and Bota, Hiroki and Ohno, Yohei and Hachinohe, Daisuke and Yamawaki, Masahiro and Ueno, Hiroshi and Mizutani, Kazuki and Otsuka, Toshiaki and Hayashida, Kentaro and OCEAN‐Mitral Investigators, OCEAN‐Mitral Investigators},
  title = {Impact of Transcatheter Edge‐to‐Edge Repair in Patients With Cardiac Sarcoidosis: Insights From the OCEAN‐Mitral Registry},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.124.039243}
}
Kostenlos starten →